SELLAS Life Sciences (SLS) Free Cash Flow (QoQ) (2010 - 2026)
SELLAS Life Sciences (SLS) Free Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.84 Bn | 1.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.43% |
| Dec 31, 2025 | 30.22% |
| Sep 30, 2025 | 3.57% |
| Jun 30, 2025 | 19.18% |
| Mar 31, 2025 | -26.80% |
| Dec 31, 2024 | 8.37% |
| Sep 30, 2024 | 19.38% |
| Jun 30, 2024 | 10.03% |
| Mar 31, 2024 | -123.03% |
| Dec 31, 2023 | 29.99% |
| Sep 30, 2023 | 8.91% |
| Jun 30, 2023 | 37.61% |
| Mar 31, 2023 | -135.38% |
| Dec 31, 2022 | 10.34% |
| Sep 30, 2022 | 0.26% |
| Jun 30, 2022 | 19.43% |
| Mar 31, 2022 | -43.69% |
| Dec 31, 2021 | 15.35% |
| Sep 30, 2021 | -20.01% |
| Jun 30, 2021 | 52.30% |